title: Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
abstract: Pulmonary arterial hypertension (PAH) occurs as an idiopathic process or as a component of a variety of disease processes, including chronic thromboembolic disease, connective tissue diseases, congenital heart disease, and exposure to exogenous factors including appetite suppressants or infectious agents such as HIV. This article reviews evidence for screening in susceptible patient groups and the approach to diagnosing PAH when it is suspected, and provides specific recommendations for applying this evidence to clinical practice.
authors.affiliation: Mayo Clinic, Rochester, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: McGoon
authors.forename: David
authors.initials: D
authors.lastname: Gutterman
authors.forename: Virginia
authors.initials: V
authors.lastname: Steen
authors.forename: Robin
authors.initials: R
authors.lastname: Barst
authors.forename: Douglas C
authors.initials: DC
authors.lastname: McCrory
authors.forename: Terry A
authors.initials: TA
authors.lastname: Fortin
authors.forename: James E
authors.initials: JE
authors.lastname: Loyd
mesh_terms: D004452:Echocardiography; D004562:Electrocardiography; D020022:Genetic Predisposition to Disease; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000235:genetics; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D010808:Physical Examination; D011651:Pulmonary Artery; D013902:Radiography, Thoracic; D012307:Risk Factors